secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLIANT THERAPEUTICS, INC. (PLRX)
CIK:        0001746473
Form:       8-K
Filed at:   2023-01-23T23:59:59+00:00
Accession:  0001193125-23-013173
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Pliant Therapeutics launches underwritten public offering; terminates ATM prospectus
--------------------------------------------------------------------------------

- Company commenced an underwritten public offering of common stock; terms not disclosed.
- No shares were sold under prior $150M ATM facility from July 2021 to January 2023.
- Existing Sales Agreement with Cantor Fitzgerald remains in effect but no sales until new prospectus filed.
- Offering made via effective shelf registration statement (Form S-3).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1746473/000119312523013173/0001193125-23-013173-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1746473/000119312523013173/d428465d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-013173

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer